Nuvectis Pharma, Inc. - NVCT
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jan 09, 2026 | Chief Dev. & Ops. Officer | A | A | 150,000.0 | 0.0 | 0.0 | 1,793,068.0 | View | |
| Jan 09, 2026 | Chairman & CEO | A | A | 150,000.0 | 0.0 | 0.0 | 3,675,924.0 | View | |
| Jan 09, 2026 | Chief Science & Business Off | A | A | 150,000.0 | 0.0 | 0.0 | 1,806,319.0 | View | |
| Jan 09, 2026 | Vice President, Finance | A | A | 61,200.0 | 0.0 | 0.0 | 200,118.0 | View | |
| Nov 06, 2025 | Chairman & CEO | P | A | 5,000.0 | 5.72 | 28,600.0 | 3,525,924.0 | View | |
| Nov 06, 2025 | — | P | A | 13,000.0 | 5.79 | 75,270.0 | 78,150.0 | View | |
| Nov 06, 2025 | — | P | A | 11,000.0 | 5.84 | 64,240.0 | 124,760.0 | View | |
| Oct 31, 2025 | — | A | A | 30,000.0 | 0.0 | 0.0 | 65,150.0 | View | |
| Oct 29, 2025 | — | P | A | 72,836.0 | 6.28 | 457,410.08 | 3,136,576.0 | View | |
| Oct 29, 2025 | — | P | A | 35,034.0 | 6.15 | 215,459.1 | 3,063,740.0 | View | |
| Oct 29, 2025 | — | P | A | 46,900.0 | 6.06 | 284,214.0 | 3,028,706.0 | View |